Review
Management of ovarian cancer risk in women with BRCA1/2 pathogenic variants
Melissa Walker, Michelle Jacobson and Mara Sobel
CMAJ August 12, 2019 191 (32) E886-E893; DOI: https://doi.org/10.1503/cmaj.190281
Melissa Walker
Department of Obstetrics and Gynaecology (Walker), University of Toronto; Department of Obstetrics & Gynaecology (Walker, Jacobson, Sobel), Women’s College Hospital; Department of Obstetrics & Gynaecology (Jacobson, Sobel), Sinai Health System, Toronto, Ont.
MD MScMichelle Jacobson
Department of Obstetrics and Gynaecology (Walker), University of Toronto; Department of Obstetrics & Gynaecology (Walker, Jacobson, Sobel), Women’s College Hospital; Department of Obstetrics & Gynaecology (Jacobson, Sobel), Sinai Health System, Toronto, Ont.
MDMara Sobel
Department of Obstetrics and Gynaecology (Walker), University of Toronto; Department of Obstetrics & Gynaecology (Walker, Jacobson, Sobel), Women’s College Hospital; Department of Obstetrics & Gynaecology (Jacobson, Sobel), Sinai Health System, Toronto, Ont.
MDArticle Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Management of ovarian cancer risk in women with BRCA1/2 pathogenic variants
Melissa Walker, Michelle Jacobson, Mara Sobel
CMAJ Aug 2019, 191 (32) E886-E893; DOI: 10.1503/cmaj.190281
Jump to section
Related Articles
Cited By...
- No citing articles found.
Podcast